异常高血苯巴比妥浓度中毒的体外治疗一例
58岁男性因服用未知剂量苯巴比妥(其猫的抗癫痫药)后深昏迷(GCS E1V1M1)就诊,血气提示高碳酸血症(PvCO2 113.0 mmHg),血苯巴比妥浓度197.3 μg/mL。到院后不久发生呼吸停止和循环衰竭,予气管插管机械通气、静脉去甲肾上腺素输注及经鼻胃管多次活性炭。6小时后血苯巴比妥浓度升至356.8 μg/mL,循环衰竭需增加去甲肾上腺素至0.13 μg/kg/min。行连续肾脏替代治疗(包括高流量连续血液透析)至住院第5天,第4天血苯巴比妥浓度降至96.2 μg/mL,自主呼吸充分恢复、循环衰竭完全改善。文献检索显示本例峰值浓度超过急性苯巴比妥中毒的致死病例及存活者。作者认为,若患者循环不稳定,可考虑连续肾脏替代治疗。
要点
- 58岁男性服未知剂量苯巴比妥后深昏迷(GCS E1V1M1),血苯巴比妥浓度197.3 μg/mL,PvCO2 113.0 mmHg。
- 到院后不久呼吸停止、循环衰竭,予插管机械通气、静脉去甲肾上腺素及经鼻胃管多次活性炭。
- 6小时后血苯巴比妥浓度升至356.8 μg/mL,循环衰竭需去甲肾上腺素增至0.13 μg/kg/min。
- 连续肾脏替代治疗(含高流量连续血液透析)至住院第5天,第4天血药浓度降至96.2 μg/mL,自主呼吸恢复、循环衰竭完全改善。
- 作者认为,体外治疗模式中若患者循环不稳定,可考虑连续肾脏替代治疗。
适用人群与场景
- 急性苯巴比妥中毒患者,尤其是出现深昏迷、呼吸停止、循环衰竭等严重表现者。
处置流程与药物剂量
- 气管插管后机械通气。
- 静脉去甲肾上腺素输注,剂量上调至0.13 μg/kg/min以维持循环。
- 经鼻胃管给予多次活性炭。
- 连续肾脏替代治疗(包括高流量连续血液透析)直至住院第5天。
红旗征与不能漏的情况
- 深昏迷(GCS E1V1M1)、高碳酸血症(PvCO2 113.0 mmHg)提示严重中毒。
- 到院后不久发生呼吸停止和循环衰竭,需立即气道管理与循环支持。
- 血苯巴比妥浓度异常升高至356.8 μg/mL伴循环衰竭需增加血管活性药剂量。
研究设计与关键结果
- 病例报告:58岁男性,服未知剂量苯巴比妥后深昏迷(GCS E1V1M1),血苯巴比妥浓度197.3 μg/mL,PvCO2 113.0 mmHg。
- 到院后呼吸停止、循环衰竭,予机械通气、静脉去甲肾上腺素、经鼻胃管多次活性炭。
- 6小时后血苯巴比妥浓度356.8 μg/mL,去甲肾上腺素增至0.13 μg/kg/min;连续肾脏替代治疗(含高流量连续血液透析)至住院第5天。
- 住院第4天血苯巴比妥浓度降至96.2 μg/mL,自主呼吸充分恢复、循环衰竭完全改善。
- 文献检索显示本例峰值苯巴比妥浓度超过急性苯巴比妥中毒致死病例及存活者的峰值浓度。
证据类型、等级与局限
- 病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,体外治疗模式中,若患者循环不稳定,可考虑连续肾脏替代治疗。
- 严重苯巴比妥中毒出现呼吸停止、循环衰竭时,需气管插管机械通气、静脉去甲肾上腺素维持循环,并可经鼻胃管给予多次活性炭。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Phenobarbital poisoning, which may cause circulatory collapse as well as respiratory arrest in severe cases, has one of the highest mortality rates among acute drug poisonings. A 58-year-old man arrived at the emergency room in a deep coma (Glasgow Coma Scale E1V1M1) after taking an unknown dose of phenobarbital which had been prescribed for his cat's seizures. Venous blood gas analysis revealed hypercapnia (PvCO2: 113.0 mmHg) and a blood phenobarbital concentration of 197.3 μg/mL. Shortly after his arrival, respiratory arrest and circulatory collapse occurred. Mechanical ventilation after intubation, intravenous noradrenaline infusion, and multiple-dose activated charcoal through a nasogastric tube was started. Six hours after arrival, blood phenobarbital concentration was abnormally elevated to 356.8 μg/mL with circulatory collapse requiring an increased dose of intravenous noradrenaline infusion (up to 0.13 μg/kg/min). Continuous renal replacement therapy including high flow continuous hemodialysis was performed until hospital day 5, during which blood phenobarbital concentration decreased to 96.2 μg/mL on hospital day 4, resulting in a sufficient resumption of spontaneous breathing and full improvement of circulatory collapse. A search of the literature revealed that the peak phenobarbital concentration in the present case exceeded those of fatal cases, as well as those of survivors of acute phenobarbital poisoning. However, the patient was successfully treated with continuous renal replacement therapy. Among modalities of extracorporeal treatment, continuous renal replacement therapy could be considered if a patient's circulation is unstable.
参考来源
- Kohara S, Kamijo Y, Seki S, et al. Poisoning by abnormally high blood phenobarbital concentration treated with extracorporeal therapy. Am J Emerg Med. 2023. PMID: 37635049. doi:10.1016/j.ajem.2023.08.034
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。